![Robert Dickey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Dickey
Directeur Financier/CFO chez
AIM IMMUNOTECH INC.
Fortune : 1 638 $ au 30/06/2026
Profil
Robert Dickey is currently Director at GSNO Therapeutics, Inc. He is Chief Financial Officer & Director at SFA Therapeutics, Inc. since 2021.
He is Chief Financial Officer at AIM ImmunoTech, Inc. since 2022.
He is Chief Financial Officer at Exxel Pharma, Inc. starting 2025.
He is Chief Financial Officer at Vyome Holdings, Inc. starting 2025.
Former roles include Chief Executive Officer & Chief Operating Officer at Protarga, Inc., Managing Director at Lehman Brothers, Inc., Director at EMI Holding, Inc. from 2018 to 2019, Director at Sanuthera, Inc. from 2013 to 2017, Managing Director at Legg Mason Wood Walker, Inc., Managing Director at Danforth Advisors LLC from 2018 to 2020, Independent Director at Emmaus Life Sciences, Inc. from 2019 to 2022, Independent Director at AngioGenex, Inc., Principal at Neuromedical Systems, Inc., Senior Vice President at AIM ImmunoTech, Inc. from 2008 to 2013, Chief Financial Officer & Senior Vice President at StemCyte, Inc., Chief Financial Officer at Invitae Corp.
in 2023, Chief Financial Officer & Vice President-Finance at Tyme Technologies, Inc. from 2015 to 2017, Chief Financial Officer at Locus Pharmaceuticals, Inc., Chief Financial Officer at Caladrius Biosciences, Inc. from 2013 to 2015, Chief Financial Officer at Motif Bio Plc from 2017 to 2018, Chief Financial Officer at Tyme, Inc. from 2015 to 2017, Chief Financial Officer at BeyondSpring Pharmaceuticals, Inc., Chief Financial Officer at NLS Pharmaceutics Ltd. from 2019 to 2021, and Chief Financial Officer at Enveric Biosciences, Inc. from 2022 to 2023.
Education includes undergraduate degree from Princeton University and MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,01 % | 02/03/2026 | 762 ( 0,01 % ) | 1 638 $ | 30/06/2026 |
AIM IMMUNOTECH INC. -.--% | 15/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Robert Dickey
| Sociétés | Poste | Début |
|---|---|---|
| AIM IMMUNOTECH INC. | Directeur Financier/CFO | 04/04/2022 |
SFA Therapeutics, Inc.
 SFA Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a platform that provides treatment services for chronic diseases | Directeur Financier/CFO | 30/12/2021 |
Exxel Pharma, Inc.
 Exxel Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics for the treatment of neuronal hypersensitivity disorders | Directeur Financier/CFO | 01/04/2025 |
Anciens postes connus de Robert Dickey
| Sociétés | Poste | Fin |
|---|---|---|
| INVITAE CORPORATION | Directeur Financier/CFO | 02/10/2023 |
| ENVERIC BIOSCIENCES, INC. | Directeur Financier/CFO | 13/03/2023 |
| EMMAUS LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 04/08/2022 |
| NLS PHARPAR | Directeur Financier/CFO | 04/04/2021 |
Danforth Advisors LLC
 Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory and operational execution services for corporate, clinical & commercial sectors | Corporate Officer/Principal | 01/03/2020 |
Formation de Robert Dickey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Neuromedical Systems, Inc.
 Neuromedical Systems, Inc. Medical SpecialtiesHealth Technology Develops, makes and markets a supplemental test to aid laboratories in the detection of abnormal cells | Health Technology |
AIM ImmunoTech, Inc.
 AIM ImmunoTech, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical drugs | Health Technology |
Protarga, Inc.
 Protarga, Inc. Miscellaneous Commercial ServicesCommercial Services Protarga, Inc. is a company based in PA. | Commercial Services |
StemCyte, Inc.
 StemCyte, Inc. Medical/Nursing ServicesHealth Services Provides baby’s precious stem cells preservation services | Health Services |
EMI Holding, Inc.
 EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases | Health Technology |
Invitae Corp.
 Invitae Corp. Medical/Nursing ServicesHealth Services Provides genetic testing services for patients | Health Services |
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Sanuthera, Inc.
 Sanuthera, Inc. Medical SpecialtiesHealth Technology Designs and manufactures medical devices to treat patients with tinnitus and hearing loss disorder | Health Technology |
Legg Mason Wood Walker, Inc.
 Legg Mason Wood Walker, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Locus Pharmaceuticals, Inc.
 Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Health Technology |
AngioGenex, Inc.
 AngioGenex, Inc. Pharmaceuticals: MajorHealth Technology Develops applications based on research into Id genes and proteins | Health Technology |
Danforth Advisors LLC
Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory and operational execution services for corporate, clinical & commercial sectors | Commercial Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Motif Bio Plc
 Motif Bio Plc Pharmaceuticals: MajorHealth Technology Develops antibiotics designed to be effective against serious and life-threatening infections | Health Technology |
Tyme, Inc.
 Tyme, Inc. BiotechnologyHealth Technology Provides research and development services focused on developing drug candidates for the treatment of cancer | Health Technology |
BeyondSpring Pharmaceuticals, Inc.
 BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative cancer therapies that improve clinical outcomes | Health Technology |
Exxel Pharma, Inc.
Exxel Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics for the treatment of neuronal hypersensitivity disorders | Health Technology |
NLS Pharmaceutics Ltd.
 NLS Pharmaceutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mental and neurobehavioral disorders | Health Technology |
Emmaus Life Sciences, Inc.
 Emmaus Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases | Health Technology |
SFA Therapeutics, Inc.
SFA Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a platform that provides treatment services for chronic diseases | Technology Services |
Enveric Biosciences, Inc.
 Enveric Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops cannabinoid medicines and combination therapies | Health Technology |
